Eyepoint Pharmaceuticals
Price & Volume
Stats
See moreOpen | $16.19 |
Previous Close | $16.23 |
Day Range | $15.36-$16.23 |
52W Range | $3.91-$19.11 |
Market Cap | $1.3B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $42.3M |
Revenue Growth (YoY) | -90.8% |
Gross Profit (12 Mos) | -$161.4M |
Diluted EPS | -$3 |
News
See moreYahoo Finance • 22 days ago
Is Rapport Therapeutics Stock a Buy After Investment Firm Cormorant Raised Its Stake Over $60 Million?
Yahoo Finance • 2 months ago
EyePoint Announces Positive Recommendation from Independent Data Safety Monitoring Committee for Pivotal Phase 3 Trials for DURAVYU™ in Wet Age-Related Macular Degeneration
Yahoo Finance • 2 months ago
EyePoint Reports Third Quarter 2025 Financial Results and Highlights Recent Corporate Developments
Yahoo Finance • 2 months ago
EyePoint to Report Third Quarter 2025 Financial Results on November 5, 2025
About
CEO | Dr. Jay S. Duker M.D. |
CFO | Mr. George O. Elston CPA |
Address | 480 Pleasant Street, Watertown, MA, United States, 02472 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 165 |
